Acute psychosis after injection of pegylated interferon alpha-2a [2]

European Psychiatry

Volumn 18, Issue 3, 2003, Pages 142-143

  Thome, J ^a   Knopf, U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENPERIDOL; CHLORPROTHIXENE; LORAZEPAM; MACROGOL; PEGINTERFERON ALPHA2B; RISPERIDONE;

ACUTE PSYCHOSIS; ADULT; ANXIETY DISORDER; CASE REPORT; CHRONIC HEPATITIS; COGNITIVE DEFECT; DELUSION; DEPRESSION; DISEASE PREDISPOSITION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INDICATION; DRUG WITHDRAWAL; FAMILY HISTORY; FATIGUE; FEMALE; HALLUCINATION; HEADACHE; HEPATITIS B; HEPATITIS C; HUMAN; INJECTION; LETTER; MENTAL INSTABILITY; MONOTHERAPY; MOOD DISORDER; MYALGIA; PARANOIA; PRIORITY JOURNAL; RESTLESSNESS; RISK ASSESSMENT; SCHIZOPHRENIA; SLEEP DISORDER; SUICIDAL BEHAVIOR; SUSTAINED DRUG RELEASE; SYMPTOM;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HEPATITIS C; HUMANS; HYPNOTICS AND SEDATIVES; INTERFERON ALFA-2A; POLYETHYLENE GLYCOLS; PSYCHOTIC DISORDERS; TREATMENT OUTCOME;

EID: 0037677801     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(03)00030-0     Document Type: Letter

References (3)

1. Barnard DL. Pegasys (Hoffmann-La Roche). Curr Opin Investig Drugs 2001;2:1530-8.
2. Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D. Interferon alpha et troubles psychiatriques. Encephale 2001;27:308-17.
3. Zeuzem S, Heathcote JE, Martin N, Nieforth K, Modi M. Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy. Expert Opin Investig Drugs 2001;10:2201-13.